Ginkgo Bioworks Holdings annual total assets
2020
2021
2022
2023
2024
2025
Ginkgo Bioworks Holdings Total Assets Growth & History (DNA)
Ginkgo Bioworks Holdings's total assets was $1.12B for fiscal 2025.
View full Ginkgo Bioworks Holdings company overviewGinkgo Bioworks Holdings annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.12B | −$257.8M | −18.71% |
| 2024 | 2024-12-31 | $1.38B | −$287.9M | −17.29% |
| 2023 | 2023-12-31 | $1.67B | −$874.0M | −34.42% |
| 2022 | 2022-12-31 | $2.54B | $468.3M | +22.61% |
| 2021 | 2021-12-31 | $2.07B | $1.40B | +206.74% |
| 2020 | 2020-12-31 | $675.2M | — | — |
Ginkgo Bioworks Holdings quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $990.0M | −$241.0M | −19.57% |
| Q1 2026 | 2026-03-31 | $1.03B | −$260.4M | −20.13% |
| Q4 2025 | 2025-12-31 | $1.12B | −$257.8M | −18.71% |
| Q3 2025 | 2025-09-30 | $1.19B | −$291.7M | −19.70% |
| Q2 2025 | 2025-06-30 | $1.23B | −$394.2M | −24.26% |
| Q1 2025 | 2025-03-31 | $1.29B | −$288.3M | −18.23% |
| Q4 2024 | 2024-12-31 | $1.38B | −$287.9M | −17.29% |
| Q3 2024 | 2024-09-30 | $1.48B | −$545.5M | −26.92% |
| Q2 2024 | 2024-06-30 | $1.63B | −$666.7M | −29.09% |
| Q1 2024 | 2024-03-31 | $1.58B | −$835.4M | −34.56% |
| Q4 2023 | 2023-12-31 | $1.67B | −$874.0M | −34.42% |
| Q3 2023 | 2023-09-30 | $2.03B | $155.7M | +8.32% |
| Q2 2023 | 2023-06-30 | $2.29B | $297.8M | +14.93% |
| Q1 2023 | 2023-03-31 | $2.42B | $359.5M | +17.47% |
| Q4 2022 | 2022-12-31 | $2.54B | $468.3M | +22.61% |
| Q3 2022 | 2022-09-30 | $1.87B | −$279.9M | −13.01% |
| Q2 2022 | 2022-06-30 | $1.99B | $268.2M | +15.54% |
| Q1 2022 | 2022-03-31 | $2.06B | $329.7M | +19.08% |
| Q4 2021 | 2021-12-31 | $2.07B | $1.40B | +206.74% |
| Q3 2021 | 2021-09-30 | $2.15B | — | — |
| Q2 2021 | 2021-06-30 | $1.73B | — | — |
| Q1 2021 | 2021-03-31 | $1.73B | — | — |
| Q4 2020 | 2020-12-31 | $675.2M | — | — |
Ginkgo Bioworks Holdings total assets trends
Over the last five fiscal years, Ginkgo Bioworks Holdings's total assets increased from $675.2M to $1.12B, a change of $444.5M. The latest reported quarter, Q2 2026, shows $990.0M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ginkgo Bioworks Holdings source filings ↗Community posts
Ginkgo joins a federally backed RNA-manufacturing project worth up to $17.5 million
Ginkgo Bioworks ($DNA) received a subcontract worth up to $17.5 million to participate in an ARPA-H program focused on RNA manufacturing. Waterfall Scientific is the prime contractor. The project, called ESCALATOR, is intended to combine co ...